5 Am Venture Management, LLC Cabaletta Bio, Inc. Transaction History

5 Am Venture Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$3.36 - $14.64 $991,200 - $4.32 Million	-295,000 Reduced 12.5%	2,064,263 $7.82 Million
Q3 2021 Nov 15, 2021	SELL	$7.0 - $12.5 $4.38 Million - $7.81 Million	-625,000 Reduced 20.94%	2,359,263 $28.7 Million
Q1 2021 May 17, 2021	SELL	$10.39 - $14.53 $4.02 Million - $5.62 Million	-387,000 Reduced 11.48%	2,984,263 $33.1 Million
Q4 2020 Feb 16, 2021	SELL	$9.81 - $15.8 $2.92 Million - $4.71 Million	-298,000 Reduced 8.12%	3,371,263 $42.1 Million
Q4 2019 Feb 05, 2020	BUY	$7.88 - $17.71 $28.9 Million - $65 Million	3,669,263 New	3,669,263 $51.3 Million

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $76M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of 5 Am Venture Management, LLC, based on Form 13F filings with the SEC.

Stay updated on 5 Am Venture Management, LLC with notifications on news.